Yüklüyor......
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
BACKGROUND: Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer. However, since oxaliplatin is associated with cumulative neurotoxicity, a shorter duration of therapy could spare toxic effe...
Kaydedildi:
| Yayımlandı: | N Engl J Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426127/ https://ncbi.nlm.nih.gov/pubmed/29590544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1713709 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|